Banco Nacional de Desenvolvimento Economico e Social Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2013
NCT01696422
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

live, attenuated, dengue serotype 1, 2, 3, 4 virus (1 trial)

tetravax-dv-tv003 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dengue (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2